Cargando…
Human antibody response to dengue virus: implications for dengue vaccine design
Dengue, a global health threat, is a leading cause of morbidity and mortality in most tropical and subtropical countries. Dengue can range from asymptomatic, relatively mild dengue fever to severe and life-threatening dengue hemorrhagic fever. Disease severity and outcome is largely associated with...
Autores principales: | Moi, Meng Ling, Takasaki, Tomohiko, Kurane, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934144/ https://www.ncbi.nlm.nih.gov/pubmed/27398060 http://dx.doi.org/10.1186/s41182-016-0004-y |
Ejemplares similares
-
Non-Human Primate Models of Dengue Virus Infection: A Comparison of Viremia Levels and Antibody Responses during Primary and Secondary Infection among Old World and New World Monkeys
por: Muhammad Azami, Nor Azila, et al.
Publicado: (2020) -
Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults
por: Saito, Yuka, et al.
Publicado: (2016) -
T-cell Responses to Dengue Virus in Humans
por: Kurane, Ichiro, et al.
Publicado: (2011) -
Dengue Virus Infection-Enhancing Activity in Serum Samples with Neutralizing Activity as Determined by Using FcγR-Expressing Cells
por: Moi, Meng Ling, et al.
Publicado: (2012) -
Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus)
por: Azami, Nor Azila Muhammad, et al.
Publicado: (2018)